BCRX
BioCryst Pharmaceuticals Inc
Price:  
7.64 
USD
Volume:  
1,305,268.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX EV/EBITDA

-192.2%
Upside

As of 2024-11-13, the EV/EBITDA ratio of BioCryst Pharmaceuticals Inc (BCRX) is -58.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BCRX's latest enterprise value is 2,316.82 mil USD. BCRX's TTM EBITDA according to its financial statements is -39.34 mil USD. Dividing these 2 quantities gives us the above BCRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.3x - 18.0x 16.8x
Forward P/E multiples 16.9x - 24.2x 19.9x
Fair Price (6.78) - (6.97) (7.05)
Upside -188.7% - -191.3% -192.2%
7.64 USD
Stock Price
(7.05) USD
Fair Price

BCRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-23 -61.10
2024-10-22 -60.52
2024-10-21 -58.26
2024-10-18 -58.78
2024-10-17 -58.10
2024-10-16 -58.52
2024-10-15 -58.05
2024-10-14 -57.94
2024-10-11 -57.78
2024-10-10 -56.15
2024-10-09 -56.84
2024-10-08 -56.57
2024-10-07 -57.84
2024-10-04 -58.57
2024-10-03 -57.73
2024-10-02 -57.52
2024-10-01 -57.52
2024-09-30 -58.68
2024-09-27 -58.78
2024-09-26 -58.57
2024-09-25 -58.41
2024-09-24 -58.84
2024-09-23 -59.68
2024-09-20 -61.36
2024-09-19 -61.57
2024-09-18 -60.57
2024-09-17 -60.36
2024-09-16 -60.31
2024-09-13 -60.36
2024-09-12 -59.47
2024-09-11 -59.36
2024-09-10 -59.31
2024-09-09 -59.05
2024-09-06 -60.68
2024-09-05 -61.46
2024-09-04 -62.25
2024-09-03 -62.10
2024-08-30 -64.41
2024-08-29 -64.09
2024-08-28 -63.67
2024-08-27 -61.99
2024-08-26 -61.99
2024-08-23 -61.31
2024-08-22 -60.41
2024-08-21 -60.83
2024-08-20 -59.83
2024-08-19 -60.04
2024-08-16 -58.89
2024-08-15 -58.84
2024-08-14 -60.04